US Patent Issued to Tsinghua University on July 12 for "Mevalonate pathway inhibitor as highly-efficient vaccine adjuvant" (Chinese Inventors)

Press/Media: Press / Media

PeriodJul 13 2022

Media coverage

1

Media coverage

  • TitleUS Patent Issued to Tsinghua University on July 12 for "Mevalonate pathway inhibitor as highly-efficient vaccine adjuvant" (Chinese Inventors)
    Media name/outletUS Fed News
    Country/TerritoryUnited States
    Date7/13/22
    PersonsMengqiang Zhao
View all 1
View less